Cases & Deals

  • Home
  • Practices
  • Genticel completes IPO on regulated markets of Euronext in Paris and Brussels

Share

Genticel completes IPO on regulated markets of Euronext in Paris and Brussels

April 2014

Client(s) Genticel S.A.

Jones Day advised Genticel, S.A., a developer of therapeutic vaccines against HPV infection with high-risk types, in connection with its €34.5 million (US$47.8 million) initial public offering of Ordinary Shares on the regulated markets of Euronext in Paris and in Brussels. Oddo & Cie and KBC Securities NV acted as joint book-running managers.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.